Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03755726 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

Study acronym: HAMA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Enrollment target: 500 to 1200
    • Primary and study completion dates: Sep 20, 2029 to Sep 20, 2034
    • Study sites: 36 to 37
    v6
  3. Study sites: 23 to 36v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jun 2029 to Sep 20, 2029
    • Start date changed from estimate of Jun 2019 to Sep 20, 2019
    v4
  5. Start date: Mar 2019 to Jun 2019
    • Primary and study completion dates: Mar 2029 to Jun 2029
    • Eligibility criteria expanded, about 12 words
    v3
  6. Lead sponsor: Romain Boulestreau to Centre Hospitalier de PAU
    • Study description expanded, about 1 word
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This registry aims to provide the first prospective, multicentric database of patients with malignant hypertension. It will allow to assess modern epidemiology of the disease, diversity of current management and care pathway, to deepen our pathophysiological knowledges, to modernize the definition of this form of hypertension and its diagnostic criteria. The network that will emerge will finally lead to the opportunity of setting up therapeutic trials and establishing recommendations based on solid scientific evidence.
Trial Details
NCT Number NCT03755726
Lead Sponsor Centre Hospitalier de PAU
Conditions
(from sponsor)		 Malignant Hypertension
Related terms Hypertension, Malignant
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov